Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$2.39 USD
-0.12 (-4.78%)
Updated May 10, 2024 04:00 PM ET
After-Market: $2.45 +0.06 (2.51%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum D VGM
Price, Consensus and EPS Surprise
NERV 2.39 -0.12(-4.78%)
Will NERV be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for NERV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NERV
Minerva Neurosciences (NERV) Upgraded to Buy: What Does It Mean for the Stock?
Here's Why Minerva Neurosciences (NERV) Is a Great 'Buy the Bottom' Stock Now
NERV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nasdaq ETF's First Six-week Rally Since Jan 2020: Stock Winners
What Makes Minerva Neurosciences (NERV) a New Buy Stock
Minerva (NERV) Down; FDA Denies Review Schizophrenia Drug NDA
Other News for NERV
Minerva price target lowered by $4 at H.C. Wainwright, here's why
NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024
Minerva Neurosciences: Q1 Earnings Snapshot
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
Minerva Neurosciences GAAP EPS of -$1.13